Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

Chentoufi AA, Dervillez X, Rubbo PA, Kuo T, Zhang X, Nagot N, Tuaillon E, Van De Perre P, Nesburn AB, Benmohamed L.

Curr Trends Immunol. 2012;13:51-68.

PMID:
23355766
[PubMed]
Free PMC Article
2.

Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.

Wang X, Xie G, Liao J, Yin D, Guan W, Pan M, Li J, Li Y.

Virol J. 2011 May 16;8:232. doi: 10.1186/1743-422X-8-232.

PMID:
21575169
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide.

Pinna D, Oreste P, Coradin T, Kajaste-Rudnitski A, Ghezzi S, Zoppetti G, Rotola A, Argnani R, Poli G, Manservigi R, Vicenzi E.

Antimicrob Agents Chemother. 2008 Sep;52(9):3078-84. doi: 10.1128/AAC.00359-08. Epub 2008 Jun 23.

PMID:
18573926
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genital herpes.

Geretti AM.

Sex Transm Infect. 2006 Dec;82 Suppl 4:iv31-4. No abstract available.

PMID:
17151051
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Wales SQ, Smith CC, Wachsman M, Calton G, Aurelian L.

Clin Diagn Lab Immunol. 2004 Jan;11(1):42-9.

PMID:
14715543
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk